Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia

Journal of Urology

Volumn 174, Issue 5, 2005, Pages 2046-2050

  Shariat, Shahrokh F ^a,b   Ashfaq, Raheela ^a   Roehrborn, Claus G ^a   Slawin, Kevin M ^b   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell proliferation; Prostate; Prostatic hyperplasia; Survivin protein, human

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; EPITHELIUM; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN EXPRESSION; RESIDUAL URINE; SCORING SYSTEM; STAINING; STATISTICAL SIGNIFICANCE; STROMA; URINE FLOW RATE; URINE VOLUME;

EID: 27544438131     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000176459.79180.d1     Document Type: Article

References (23)

1. Kyprianou, N., Tu, H. and Jacobs, S. C.: Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol, 27: 668, 1996
2. Colombel, M., Vacherot, F., Diez, S. G., Fontaine, E., Buttyan, R. and Chopin, D.: Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia. Br J Urol, 82: 380, 1998
3. Vacherot, F., Azzouz, M., Gil-Diez-De-Medina, S., Colombel, M., De La Taille, A., Lefrere Belda, M. A et al: Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr), Permixon in benign prostatic hyperplasia. Prostate, 45: 259, 2000
4. Claus, S., Berges, R., Senge, T. and Schulze, H.: Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. J Urol, 158: 217, 1997
5. Altieri, D. C.: Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene, 22: 8581, 2003
6. Shariat, S. F., Lotan, Y., Saboorian, H., Khoddami, S. M., Roehrborn, C. G., Slawin, K. M. et al: Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer, 100: 751, 2004
7. Blanc-Brude, O. P., Mesri, M., Wall, N. R., Plescia, J., Dohi, T. and Altieri, D. C.: Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res, 9: 2683, 2003
8. Arun, B., Kilic, G., Yen, C., Foster, B., Yardley, D., Gaynor, R. et al: Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Cancer, 98: 2554, 2003
9. Winter, R. N., Kramer, A., Borkowski, A. and Kyprianou, N.: Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res, 61: 1227, 2001
10. Schorge, J. O., Lea, J. S., Elias, K. J., Rajanbabu, R., Coleman, R. L., Miller, D. S. et al: P16 as a molecular biomarker of cervical adenocarcinoma. Am J Obstet Gynecol, 190:668, 2004
11. Shariat, S. F., Menesses-Diaz, A., Kim, I. Y., Muramoto, M., Wheeler, T. M. and Slawin, K. M.: Tissue expression of transforming growth factor-beta 1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy. Urology, 63: 1191, 2004
12. Wang, S., Saboorian, M. H., Frenkel, E. P., Haley, B. B., Siddiqui, M. T., Gokaslan, S. et al: Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol, 116: 495, 2001
13. Kyprianou, N., Litvak, J. P., Borkowski, A., Alexander, R. and Jacobs, S. C.: Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia. J Urol, 159: 1810, 1998
14. Shapiro, E., Becich, M. J., Hartanto, V. and Lepor, H.: The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol, 147: 1293, 1992
15. Barry, M. J., Cockett, A. T., Holtgrewe, H. L., McConnell, J. D., Sihelnik, S. A. and Winfield, H. N.: Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol, 150: 351, 1993
16. Cardillo, M., Berchem, G., Tarkington, M. A., Krajewski, S., Krajewski, M., Reed, J. C. et al: Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation. J Urol, 158: 212, 1997
17. Sadeghi, F., Shariat, S. F., Song, W., Nguyen, C., Spencer, D. M. and Slawin, K. M.: Apoptosis induction by CID-regulated caspases: in vivo success of a novel suicide gene therapy approach to BPH. J Urol, suppl., 163: 204, abstract 906, 2000
18. Mazerolles, C., Rishmann, P., Chopin, D., Popov, Z., Malavaud, B., Selves, J. et al: Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody. Histopathology, 25: 563, 1994
19. Glynne-Jones, E., Harper, M. E., Goddard, L., Eaton, C. L., Matthews, P. N. and Griffiths, K.: Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate, 25: 210, 1994
20. Sutkowski, D. M., Fong, C. J., Sensibar, J. A., Rademaker, A. W., Sherwood, E. R., Kozlowski, J. M. et al: Interaction of epidermal growth factor and transforming growth factor beta in human prostatic epithelial cells in culture. Prostate, 21: 133, 1992
21. Kyprianou, N. and Isaacs, J. T.: Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology, 122: 552, 1988
22. Timme, T. L., Yang, G., Truong, L. D., Kadmon, D., Park, S. H. and Thompson, T. C.: Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities. World J Urol, 13: 324, 1995
23. Bretland, A. J., Reid, S. V., Chapple, C. R. and Eaton, C. L.: Role of endogenous transforming growth factor beta (TGFbeta)1 in prostatic stromal cells. Prostate, 48: 297, 2001